跳至主要内容
临床试验/EUCTR2011-005554-62-GB
EUCTR2011-005554-62-GB进行中(未招募)1 期

Pharmacokinetics and Pharmacodynamics of Doxorubicin in Children, Adolescents and young adults with Newly Diagnosed Osteosarcoma, Ewing Family of Tumours and Hodgkin LymphomaA Multi-Institutional Cross-Discipline Non-Therapeutic Study - AYAPK- Adolescents and Young Adults PK

Australian Sarcoma Group (ASSG)0 个研究点目标入组 210 人开始时间: 2012年3月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
210

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Newly diagnosed with osteosarcoma, Ewing family of tumours or Hodgkin lymphoma
  • - =1 year and 40years of age (in the UK only patients aged 11 - 40 years will be recruited)
  • - Planned treatment involves standard of care doxorubicin-containing regimens.
  • - Written informed consent from patient and/or patient’s parent or legal guardian.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 80
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • - Impaired hepatic function such as known chronic liver disease, evidence of impaired synthetic function or transaminases raised >5 x normal
  • - Significant uncontrolled systemic illness as judged by investigator
  • - Females who are pregnant or breast feeding

研究者

发起方
Australian Sarcoma Group (ASSG)

相似试验

A study investigating the pharmcokintetics (how the... | 临床试验